- Testosterone prior to hypospadias repair : no clear-cut benefit or reassurance regarding long-term safety
- Evaluation of novel treatments in prostate cancer : concerning innovations in the field of minimal-invasive surgery, whole-pelvis radiotherapy and hormonal therapy with abiraterone acetate
- Influence of dartos tissue and the androgen receptor in congenital penile malformations : opening new horizons in research with clinical relevance
- Which factors predict overall survival in patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate post-docetaxel?
- Release of urinary extracellular vesicles in prostate cancer is associated with altered urinary N-glycosylation profile
- Androgen receptor gene copy number and protein expression in treatment-naïve prostate cancer
Abiraterone acetate post-docetaxel for metastatic castration-resistant prostate cancer in the Belgian compassionate use program
2016) UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. 34(6). p.254.e7-254.e13 Mark(
- What kind of prostate cancers do we miss on multiparametric magnetic resonance imaging?
- Evaluation of abiraterone acetate post-docetaxel in the Belgian compassionate use program
Battling resistance mechanisms in antihormonal prostate cancer treatment: novel agents and combinations
2015) UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. 33(7). p.310-321 Mark(